Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

被引:11
|
作者
Therachiyil, Lubna [1 ,2 ]
Hussein, Ola J. [1 ]
Uddin, Shahab [2 ,3 ]
Korashy, Hesham M. [1 ,4 ]
机构
[1] Qatar Univ, Coll Pharm, Dept Pharmaceut Sci, QU Hlth, Doha, Qatar
[2] Hamad Med Corp, Translat Res Inst, Acad Hlth Syst, Doha, Qatar
[3] Hamad Med Corp, Dermatol Inst, Acad Hlth Syst, Doha, Qatar
[4] Qatar Univ, Coll Pharm, Doha, Qatar
关键词
Aryl hydrocarbon receptor; Chemoresistance; Gynecological cancers; Stemness markers; Cancer stem cells; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN OVARIAN-CANCER; SIDE-POPULATION CELLS; BREAST-CANCER; ENDOMETRIAL CANCER; ALDEHYDE DEHYDROGENASE; AH-RECEPTOR; STEM/PROGENITOR CELLS; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR;
D O I
10.1016/j.semcancer.2022.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gynecological malignancies are a female type of cancers that affects the reproductive system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at advanced stages of cancer progression. Cancer Stem Cells (CSCs) enrichment in tumors leads to chemoresistance, which results in cancer mortality. Exposure to environmental pollutants such as polycyclic aromatic hydrocarbons is associated with an increased the risk of CSC enrichment in gynecological cancers. One of the important pathways that mediates the metabolism and bioactivation of these environmental chemicals is the transcription factor, aryl hydrocarbon receptor (AhR). The present review explores the molecular mechanisms regulating the crosstalk and interaction of the AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in several gynecological malignancies such as ovarian, uterine, endometrial, and cervical cancers. The review also discusses the potential of targeting the AhR pathway as a novel chemo-therapy for gynecological cancers.
引用
收藏
页码:1186 / 1202
页数:17
相关论文
共 50 条
  • [1] Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
    Akhtar, Sabah
    Hourani, Shireen
    Therachiyil, Lubna
    Al-Dhfyan, Abdullah
    Agouni, Abdelali
    Zeidan, Asad
    Uddin, Shahab
    Korashy, Hesham M.
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 177 - 196
  • [2] Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
    Zeng, Zhen
    Fu, Minyang
    Hu, Yuan
    Wei, Yuquan
    Wei, Xiawei
    Luo, Min
    MOLECULAR CANCER, 2023, 22 (01)
  • [3] Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
    Zhen Zeng
    Minyang Fu
    Yuan Hu
    Yuquan Wei
    Xiawei Wei
    Min Luo
    Molecular Cancer, 22
  • [4] Aryl hydrocarbon receptor (AhR) regulation of inflammation and cancer
    Platten, Michael
    TOXICOLOGY LETTERS, 2013, 221 : S29 - S29
  • [5] Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
    Manni, Wang
    Min, Wu
    MEDCOMM, 2022, 3 (04):
  • [6] Aryl Hydrocarbon Receptor and Stem Cells
    Gasiewicz, Thomas A.
    Singh, Kameshwar P.
    Casado, Fanny L.
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [7] Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells
    Jiuheng Yin
    Baifa Sheng
    Aimin Pu
    Bin Han
    Kunqiu Yang
    Qimeng Wang
    Lihua Sun
    Hua Yang
    Digestive Diseases and Sciences, 2016, 61 : 444 - 452
  • [8] Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells
    Yin, Jiuheng
    Sheng, Baifa
    Pu, Aimin
    Han, Bin
    Yang, Kunqiu
    Wang, Qimeng
    Sun, Lihua
    Yang, Hua
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (02) : 444 - 452
  • [9] Signaling Pathways in Cancer and Embryonic Stem Cells
    Oliver Dreesen
    Ali H. Brivanlou
    Stem Cell Reviews, 2007, 3 : 7 - 17
  • [10] Cancer stem cells and signaling pathways in radioresistance
    Chang, Lei
    Graham, Peter
    Hao, Jingli
    Ni, Jie
    Deng, Junli
    Bucci, Joseph
    Malouf, David
    Gillatt, David
    Li, Yong
    ONCOTARGET, 2016, 7 (10) : 11002 - 11017